Market Analysis
AZTR Did a Reverse Split and Posted Skin Data the Same Morning
Azitra announced cosmetic skin-explant results on its first split-adjusted trading day. What the experiment and price comparison can establish.
Lead story · No. 039
Market Analysis
Azitra announced cosmetic skin-explant results on its first split-adjusted trading day. What the experiment and price comparison can establish.
Market Analysis
CLRO momentum, AIOK’s follow-through, AZTR’s split and study, SPRC’s after-hours financing, XTND’s revenue and XNCR’s early trial data.
Market Analysis
SciSparc cut the exercise price on 405,728 warrants. Read the cash proceeds, current share count and 4.99% blocker separately.
Market Analysis
Xencor chose a proposed dose for XmAb819. Separate confirmed responses, PFS estimates, safety cohorts and the still-unsettled approval pathway.
Market Analysis
XTEND disclosed preliminary nine-month revenue and an $84 million robotics backlog. Why the period, acquisition and delivery terms matter.
Reading the session
Learn how gap up and gap down are calculated, how opening gaps differ from premarket changes, and why the reference price and timestamp matter.
Data study
A look at 671 US stock gap-ups of 20% or more from July 1 to October 2, 2026: when the 4:00 a.m.–8:00 p.m. ET high printed, split by gap size, price and how the day ended.
Research process
Research why a stock moved using company announcements, SEC filings, and a source-linked timeline. Separate confirmed events from explanations and unknowns.
Retrospective data built after the session from stored records, with links to the original sources. Not real-time, not investment advice and not a recommendation to buy or sell any security.